Trial
NCT03586284
Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Francisco
Collaborators
Huang Pacific Foundation; Khon Kaen University; King Chulalongkorn Memorial Hospital
Condition
Cytomegalovirus Anterior Uveitis
Intervention
Valganciclovir Hydrochloride
Why stopped
Funding discontinued.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-05